Surgery Partners Executive Compensation (FY25)
SGRY · Brentwood, TN · Executive and director compensation, fiscal 2022 to 2025
The paid brief on Surgery Partners
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Data as of September 17, 2026Latest filing (8-K): June 5, 2026
16 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
$1,500Get the executive brief
345 figures on this page: 336 cited to the filing that reported them, 9 calculated from figures it prints. See the citations
More on Surgery Partners
Five data products on this company. Each one is requested through the developer setup page.
- Peer Disclosure Audit$5The comparison companies this board named, each one tied to the filing that lists it.How to get Peer Disclosure Audit
- Governance Provisions PullfreeThe governance provisions as the proxy states them: board leadership, committee membership, and shareholder rights.How to get Governance Provisions Pull
- Say-on-Pay Risk Signal$9A risk band for the next say-on-pay vote, with the support history and the peer comparison behind it.How to get Say-on-Pay Risk Signal
- NEO Comp Report$24Every named executive officer’s pay by element and year, with the citation behind each figure.How to get NEO Comp Report
- Board Comp Report$24What each non-employee director was paid, the standing fee schedule, and the equity each one holds at year end.How to get Board Comp Report
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
CEO pay ratio: 119:1 → 112:1 (5.9% lower)
Frequently asked questions
Answers drawn from the data on this page.
Who is Surgery Partners' chief executive and what were they paid?
J. Eric Evans was paid $6,083,862 in total compensation as Chief Executive Officer for fiscal 2025.
What was Surgery Partners' say-on-pay result?
The say-on-pay proposal drew 98.2% support at the meeting held June 5, 2026 for fiscal 2025.
Which companies are in Surgery Partners' peer group?
The disclosed peer group names Acadia Healthcare Company, Inc., Amedisys, Inc., AMN Healthcare Services, Inc., Brookdale Senior Living Inc. and Chemed Corporation, among others.
What is Surgery Partners' chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 112:1, against median employee compensation of $54,477.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
J. Eric Evans Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Harrison Bane President, National Group | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
David Doherty Executive Vice President and Chief Financial Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Bradley Owens Former President, National Group Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Jennifer Baldock Executive Vice President Chief Administrative and Development Officer | ◇ | — | ◇ | — | ◇ | ◇ | ◇ | ◇† |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
J. Eric Evans Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
David Doherty Executive Vice President and Chief Financial Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Jennifer Baldock Executive Vice President, Chief Administrative and Development Officer | ◇ | — | ◇ | — | ◇ | ◇ | ◇ | ◇ |
Marissa Brittenham Executive Vice President and Chief Strategy Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Bradley Owens Former President, National Group | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Harrison Bane Former President, National Group | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
J. Eric Evans Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | — not reconciled |
David Doherty Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Jennifer Baldock Executive Vice President, Chief Administrative and Development Officer | ◇ | — | ◇ | — | ◇ | ◇ | ◇ | ◇ |
Bradley Owens Former President, National Group Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Anthony Taparo Former Chief Growth Officer Departed during or after this year | ◇ | — | ◇ | — | ◇ | ◇ | ◇ | ◇ |
Harrison Bane Former President, National Group | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Marissa Brittenham Executive Vice President and Chief Strategy Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
J. Eric Evans Chief Executive Officer | ◇ | — | ◇ | — | — | ◇ | ◇ | ◇ |
David Doherty Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Jennifer Baldock Executive Vice President, Chief Administrative and Development Officer | ◇ | — | ◇ | — | — | ◇ | ◇ | ◇ |
Harrison Bane Former President, National Group Departed during or after this year | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
W. Trent Webb President, American Group | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Marissa Brittenham Executive Vice President and Chief Strategy Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| David T. Doherty | Restricted Stock | ◇ | — | — | ◇ | — | — | ◇ |
| David T. Doherty | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Harrison R. Bane | Restricted Stock | ◇ | — | — | ◇ | — | — | ◇ |
| Harrison R. Bane | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| J. Eric Evans | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| J. Eric Evans | Restricted Stock | ◇ | — | — | ◇ | — | — | ◇ |
| Jennifer B. Baldock | Restricted Stock | ◇ | — | — | ◇ | — | — | ◇ |
| Jennifer B. Baldock | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Marissa A. Brittenham | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Marissa A. Brittenham | Restricted Stock | ◇ | — | — | ◇ | — | — | ◇ |
| W. Trent Webb | Restricted Stock | ◇ | — | — | ◇ | — | — | ◇ |
| W. Trent Webb | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
Fiscal 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| J. Eric Evans | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Marissa Brittenham | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| W. Trent Webb | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| David Doherty | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Jennifer Baldock | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
David Doherty
Executive Vice President and Chief Financial Officer · Employment agreement · citing a 2022 filing
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
| Clawback | ◇ |
Jennifer Baldock
Executive Vice President, Chief Administrative and Development Officer · Employment agreement · citing a 2022 filing
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
| Clawback | ◇ |
Marissa Brittenham
Executive Vice President and Chief Strategy Officer · Employment agreement · citing a 2022 filing
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
| Clawback | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Brent Turner | ◇ | ◇ | — | — | — | — | ◇ |
Teresa DeLuca, M.D | ◇ | ◇ | — | — | — | — | ◇ |
John A. Deane | ◇ | ◇ | — | — | — | — | ◇ |
Laura L. Forese, M.D | ◇ | ◇ | — | — | — | — | ◇ |
Patricia A. Maryland, Dr.PH | ◇ | ◇ | — | — | — | — | ◇ |
Blair E. Hendrix Board chair | ◇ | ◇ | — | — | — | — | ◇ |
Clifford G. Adlerz | ◇ | ◇ | — | — | — | — | ◇ |
Wayne S. DeVeydt | ◇ | — | — | — | — | — | ◇ |
Lloyd Dean, J. Eric Evans, Devin O'Reilly and Andrew T. Kaplan served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Audit committee chair | ◇ |
| Compensation committee chair | ◇ |
| Nominating and governance chair | ◇ |
Equity is delivered as Restricted Stock.
Stock ownership guideline: 5x annual retainer ($500,000)
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Acadia Healthcare Company, Inc. ACHC
- Amedisys, Inc. AMED
- AMN Healthcare Services, Inc. AMN
- Brookdale Senior Living Inc. BKD
- Chemed Corporation CHE
- Encompass Health Corporation EHC
- ModivCare Inc. MODV
- Option Care Health, Inc. OPCH
- Pediatrix Medical Group, Inc. MD
- Premier, Inc. PINC
- RadNet, Inc. RDNT
- Select Medical Holdings Corp SEM
- The Ensign Group, Inc. ENSG
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | June 5, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | June 6, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | June 6, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | June 1, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | May 19, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | May 26, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | May 27, 2020 | = | ◇ | ◇ | ◇ |
| 2018 | May 29, 2019 | = | ◇ | ◇ | ◇ |
| 2017 | May 4, 2018 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
What this page does not include
Everything above is a fact Surgery Partners disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Surgery Partners sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
345 figures on this page: 336 cited to the filing that reported them, 9 calculated from figures it prints.
336 cited to the filing
9 calculated from the filing
Documents cited
- 0001638833-26-000050Proposal 2: Advisory vote on executive compensation.
- 0001638833-26-000039CEO Pay Ratio · DIRECTOR COMPENSATION · Grants of Plan-Based Awards · Outstanding Equity Awards at Fiscal Year-End · and 1 more section
- 0001638833-25-000096Proposal 2: Advisory vote on executive compensation.
- 0001638833-25-000084Summary Compensation Table
- 0001638833-24-000127Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001638833-24-000106Summary Compensation Table
- 0001638833-23-000074Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001638833-23-000063Summary Compensation Table
- 0001638833-22-000102Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001638833-21-000126Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001638833-20-000045Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001638833-19-000042Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001104659-18-031295Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001638833-22-000002EX-10.25
- 0001638833-22-000096EX-10.22
- 0001638833-22-000019EX-10.26
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Surgery Partners executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/SGRY (accessed 2026).
Short form: data: Velarion
The paid brief for Surgery Partners
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
16 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Surgery Partners and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Peers Surgery Partners discloses
The companies named in SGRY's own disclosed peer group.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}